1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Demyelinating Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barnes, GN; Cai, J; Chu, T; Kong, M; Shields, CB; Shields, LBE; Tian, Z; Wang, Y; Zhang, YP; Zhu, Q	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Demyelinating Diseases

Article	Year
Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects. Molecular neurobiology, 2020, Volume: 57, Issue:10 Topics: Animals; Cerebellum; Cytokines; Demyelinating Diseases; Gene Deletion; Inflammation Mediators; Lysophosphatidylcholines; Mice, Inbred C57BL; Mice, Knockout; Microglia; Myelin Basic Protein; Neurofilament Proteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Transcription, Genetic	2020

Article

Year

Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.

Molecular neurobiology, 2020, Volume: 57, Issue:10

Topics: Animals; Cerebellum; Cytokines; Demyelinating Diseases; Gene Deletion; Inflammation Mediators; Lysophosphatidylcholines; Mice, Inbred C57BL; Mice, Knockout; Microglia; Myelin Basic Protein; Neurofilament Proteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Transcription, Genetic

2020